Quality Assurance & Regulatory Compliance
Our quality framework centers on authentic manufacturer due diligence, strict pharmacopoeial conformity, and proactive pharmacovigilance.
Biopytix Pharmaceuticals Pvt. Ltd. discloses only verified factual compliance procedures. Individual manufacturing facilities holding licenses for our products operate in compliance with Schedule M of the Drugs and Cosmetics Act (India). Certificates of Analysis (COA) are generated for each production batch.
Facility Qualification & Due Diligence
We partner exclusively with manufacturing units holding valid State Drug Authority licenses, Schedule M compliance, and certified analytical laboratories.
Pharmacopoeial Conformity (IP/BP/USP)
Finished dosage forms undergo rigorous assay testing, dissolution profiles, uniform weight verification, and microbial limit testing against official monograph standards.
Batch Integrity & Packaging Stability
Products are packaged in moisture-barrier Alu-Alu blister foils, PVDC strips, or specialized amber containers designed to safeguard stability across Indian climate zones.
Pharmacovigilance & Complaint Redressal
We operate a dedicated adverse drug reaction (ADR) intake desk and complaint logging system. All reported events are forwarded to regulatory safety officers.
Adverse Event & Pharmacovigilance Reporting
Healthcare professionals, chemists, and consumers are urged to report any unexpected adverse event, suspected defect, or product quality issue immediately to our regulatory compliance desk.